High-dose chemotherapy and autologous CD34-positive blood stem cell transplantation for multiple myeloma in an HIV carrier

The epidemiology and clinical outcome of multiple myeloma in human immunodeficiency virus (HIV)-positive patients is poorly documented. There are uncertainties concerning the optimal management of this rare disorder. We report on the use of myeloablative chemotherapy with autologous stem cell transp...

Full description

Saved in:
Bibliographic Details
Published inBone marrow transplantation (Basingstoke) Vol. 29; no. 3; pp. 273 - 275
Main Authors KENTOS, A, VEKEMANS, M, VAN VOOREN, J. P, LAMBERMONT, M, LIESNARD, C, FEREMANS, W, FARBER, C. M
Format Journal Article
LanguageEnglish
Published Basingstoke Nature Publishing Group 01.02.2002
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The epidemiology and clinical outcome of multiple myeloma in human immunodeficiency virus (HIV)-positive patients is poorly documented. There are uncertainties concerning the optimal management of this rare disorder. We report on the use of myeloablative chemotherapy with autologous stem cell transplantation in an HIV-positive patient with multiple myeloma.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0268-3369
1476-5365
DOI:10.1038/sj.bmt.1703348